Tobacco Products Act Changes
HB268 makes substantial changes to New Mexico’s Tobacco Products Act focused on electronic nicotine delivery systems (ENDS) and nicotine liquids, including e-cigarettes and vape liquids. The bill adds definitions for “snuff” and “timely filed premarket tobacco product application,” and it expands enforcement authority by giving the State Department of Justice concurrent authority with the Division over enforcement of the new ENDS/nicotine-liquid registration provisions. It also clarifies reporting duties for law enforcement and the Division when violations are cited.
The core of the bill creates a product-registration and directory system for ENDS and nicotine liquids sold in New Mexico. By August 1, 2025, manufacturers must certify that each product has either received FDA marketing authorization or has a timely filed premarket tobacco product application that remains pending or otherwise protected by FDA/court action. Manufacturers must list each brand, product, category, and flavor, pay a $250 fee per product, and update the Division on material changes. The Division must publish and maintain a public directory of approved manufacturers and products, and products not listed in the directory generally may not be sold in the state after the applicable grace periods.
HB268 also imposes compliance and enforcement mechanisms. It authorizes seizure, forfeiture, and destruction of nonlisted products, sets escalating civil penalties for retailers and distributors that sell unlisted products, and imposes a $10,000-per-product civil penalty on manufacturers that cause unlisted products to be sold in New Mexico. False statements in certifications are made a misdemeanor, repeat violations can be treated as unfair or deceptive trade practices, and out-of-state or foreign manufacturers must appoint a registered agent and, in some cases, post a $25,000 surety bond. The bill requires at least two unannounced compliance checks per year for retailers and distributors, directs the Division to adopt rules, and dedicates fees and penalties to the tobacco products administration fund.
The bill’s impact on state law is to tighten regulation of vape and nicotine-liquid products by creating a state-level market authorization filter tied to FDA status, while also giving state agencies stronger tools to police the supply chain. It would affect manufacturers, importers, distributors, retailers, and consumers by limiting what products can be sold, increasing compliance obligations, and creating a public directory that determines lawful sale in New Mexico. It also shifts some enforcement responsibility to the Department of Justice and adds new reporting requirements to the Legislature beginning in 2026.
No committee transcripts or recorded votes were provided, so there is no documented floor or committee sentiment in the materials. Based on the bill text alone, the measure appears designed to strengthen youth and consumer protections and improve enforcement against unauthorized vape products, but it also places significant administrative and financial burdens on manufacturers and sellers. Likely points of contention include the directory/listing requirement, the per-product fees, the surety bond requirement for nonresident manufacturers, the seizure and destruction provisions, and whether the bill could restrict access to products that are still under FDA review.
HB268 amends the Tobacco Products Act to add new definitions and create a comprehensive registration-and-directory regime for electronic nicotine delivery systems and nicotine liquids. It requires manufacturer certifications, public listing of approved products, compliance checks, reporting, penalties, and bonding requirements, while also expanding enforcement authority to the State Department of Justice for the new section. The bill would directly affect tobacco/nicotine manufacturers, importers, distributors, retailers, and consumers by limiting sales to products listed in the state directory and by authorizing seizure and sanctions for noncompliance.
No committee discussion or vote history was provided, so there is no recorded legislative sentiment to summarize. From the bill text, the measure appears generally protective and enforcement-oriented, with an apparent policy goal of restricting unauthorized vape products and improving oversight. At the same time, the bill imposes substantial compliance costs and operational requirements, suggesting that support would likely come from public-health and enforcement interests, while opposition would likely come from affected industry stakeholders.
The main points of contention are likely to be the scope and strictness of the new directory system, the requirement that products be tied to FDA authorization or a timely filed application, and the financial burdens imposed on manufacturers through per-product fees and surety bonds. Retailers and distributors may object to the risk of seizure, forfeiture, license suspension, and permanent revocation for selling unlisted products, while manufacturers may challenge the reporting, agent-for-service, and compliance obligations, especially for out-of-state and foreign companies. Another likely issue is whether the bill could remove products from the market even when they are still under FDA review or subject to litigation.